Sarilumab Effect on the Pharmacokinetics of Simvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

sarilumab SAR153191 (REGN88)

Pharmaceutical form:Prefilled syringe of sarilumab solution Route of administration: Subcutaneous injection

DRUG

simvastatin

Pharmaceutical form:Film-coated 20 mg Tablet Route of administration: oral

Trial Locations (5)

2025

Investigational Site Number 498001, Chisinau

16635

Investigational Site Number 840002, Duncansville

38305

Investigational Site Number 840003, Jackson

75235

Investigational Site Number 840001, Dallas

110-744

Investigational Site Number 410002, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY